Masaru Matsuda, See Remark at Arcutis Biotherapeutics, Inc. (ARQT), sold 1,830 shares at $7.80 ($14K) on 2023-05-31, disclosed to the SEC on 2023-06-02.
Open-market sale of $14k ARQT by See Remark. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ARQT | SELL | 2026-08-05 | $32K | — | Filing → |
| ARQT | SELL | 2026-05-06 | $192K | — | Filing → |
| ARQT | SELL | 2026-03-03 | $314K | — | Filing → |